Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook
Vanda Pharmaceuticals Inc. · PHARMACEUTICAL PREPARATIONS · Now $6.45
-4.9% in 7d after detection
Post-detection moves
1h
—
1d
-1.7%
3d
+0.5%
7d
-4.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS